Intensified Adjuvant IFADIC Chemotherapy for Adult Soft Tissue Sarcoma: A Prospective Randomized Feasibility Trial. - Wikidata - wikimedia - TriplyDB

Intensified Adjuvant IFADIC Chemotherapy for Adult Soft Tissue Sarcoma: A Prospective Randomized Feasibility Trial.

Intensified Adjuvant IFADIC Chemotherapy for Adult Soft Tissue Sarcoma: A Prospective Randomized Feasibility Trial.

http://www.wikidata.org/entity/Q36674048

about

Adjuvant chemotherapy in soft tissue sarcomas…Conflicts, consensus, and controversies Definitive radiotherapy and single-agent radiosensitizing ifosfamide in patients with localized, irresectable soft tissue sarcoma: a retrospective analysis.Phase I trial of neoadjuvant conformal radiotherapy plus sorafenib for patients with locally advanced soft tissue sarcoma of the extremity.Chemotherapy is associated with improved survival in adult patients with primary extremity synovial sarcoma.Synovial sarcoma: retrospective analysis of 250 patients treated at a single institution.Dose-intensive chemotherapy in advanced adult soft tissue sarcoma.Multidisciplinary management of soft-tissue sarcomas.Adjuvant therapy for extremity sarcomas.Controversies in surgical oncology: routine anthracycline-based adjuvant chemotherapy for stage III extremity soft tissue sarcoma.Adjuvant chemotherapy following complete resection of soft tissue sarcoma in adults: a clinical practice guideline Adult human sarcomas. II. Medical oncology.Tumor-associated fibroblasts promote the proliferation and decrease the doxorubicin sensitivity of liposarcoma cells.Centralised treatment of soft tissue sarcomas in adults.Combination of Cisplatin, Ifosfamide, and Adriamycin as Neoadjuvant Chemotherapy for Extremity Soft Tissue Sarcoma: A Report of Twenty-Eight Patients Role of chemotherapy in the management of soft tissue sarcomas.Anti‑proliferative activity of epigallocatechin‑3‑gallate and silibinin on soft tissue sarcoma cells.Neoadjuvant sequential chemoradiotherapy versus radiotherapy alone for treatment of high-risk extremity soft tissue sarcoma: a single-institution experience Treating soft tissue sarcomas with adjuvant chemotherapy.Adjuvant chemotherapy of soft tissue sarcoma-current status Evaluation of the safety and efficacy of TRAIL and taurolidine use on human fibrosarcoma xenografts in vivo.Intensified adjuvant IFADIC chemotherapy in combination with radiotherapy versus radiotherapy alone for soft tissue sarcoma: long-term follow-up of a prospective randomized feasibility trial.Adjuvant chemotherapy in 2011 for patients with soft-tissue sarcoma.The impact of re-excision of inadequately resected soft tissue sarcomas on surgical therapy, results, and prognosis: A single institution experience with 682 patients.The impact of chemotherapy on the survival of patients with high-grade primary extremity liposarcoma.Neo-adjuvant chemotherapy for primary high-grade extremity soft tissue sarcoma.[Soft tissue sarcoma: how can posttreatment alterations be distinguished from recurrences?]Doxorubicin-based adjuvant chemotherapy in soft tissue sarcoma: pooled analysis of two STBSG-EORTC phase III clinical trials.Controversies and consensus of neoadjuvant chemotherapy in soft-tissue sarcomas.

P2860

Q26750588-A2864191-7CDC-4B70-AA17-86071D9A5CFF Q33952091-D5B9F96C-F613-4B5B-89A1-FD181DCF00C7 Q34129496-99778EE0-202F-4A98-BD2D-2E5DF7F964F2 Q34580595-F01D9BE4-1B39-473D-9CE7-5AD82578A2FB Q34607877-B5C5A684-5D38-4BB5-8553-676AC62A226B Q34734533-FBFF8092-ADC3-4C7B-B1E7-3B0DCF756C5B Q34798740-64BCFA7A-5F60-4368-B94D-30DD4EF28DC7 Q36619770-D9BC0A80-FC74-4C28-89D4-F697A09EFAB5 Q36653372-70DB11AB-C9B9-4F65-B1BE-D59E4C482A1D Q36674152-E058776D-014A-4A7B-8A93-7E1BB3F8D48F Q36731430-67C3CCC5-9139-4C57-A74C-2AA80CA0AC66 Q36903707-3771AACA-B4AF-4376-8FCA-5ED10F08C4E3 Q37079451-281CBDBD-DACD-492C-A05A-D9C9EE14F263 Q37624123-70B28716-F7C1-4F8D-92AC-1EC441366723 Q37687389-2A674B54-5BFF-4E8F-A244-4BDD4865DB8D Q37707691-21B09253-7313-435B-A59D-DDB0AA1D3C68 Q37743151-ADA6CBEB-A8A3-4950-9F02-C36CBF1267F7 Q37850703-90BFE24B-237C-44F9-90C1-99DB3BEE6B56 Q38612697-678BE57A-F37A-47EA-AB32-2A963B4AA5D4 Q38721053-A9082706-50F4-4C85-B572-BEEC9A5362E1 Q42852065-E9150997-0D11-44D7-88F0-F2396DA400E2 Q44882085-7A0F408D-4E05-41E4-AE34-0B7F2A34B847 Q44991369-BAA7EB25-F90E-4370-80BD-4EA31E460FB6 Q45071414-D391E18A-18B3-43A5-92B2-5DC46CCEBA21 Q45133928-B807A236-AC82-41BE-9DD4-7071490E61BF Q50077874-27182832-F5A8-483C-B6DA-7C42C4937BE6 Q52873305-BA919401-CD41-4C17-B1B9-66FED7701B4F Q55686663-E5052E73-50EE-4E64-A38A-43DBC149624A

P2860

Intensified Adjuvant IFADIC Chemotherapy for Adult Soft Tissue Sarcoma: A Prospective Randomized Feasibility Trial.

http://www.wikidata.org/entity/Q36674048

description

2000 nî lūn-bûn

@nan

2000年の論文

@ja

2000年論文

@yue

2000年論文

@zh-hant

2000年論文

@zh-hk

2000年論文

@zh-mo

2000年論文

@zh-tw

2000年论文

@wuu

2000年论文

@zh

2000年论文

@zh-cn

name

Intensified Adjuvant IFADIC Ch ...... Randomized Feasibility Trial.

@ast

Intensified Adjuvant IFADIC Ch ...... Randomized Feasibility Trial.

@en

type

label

Intensified Adjuvant IFADIC Ch ...... Randomized Feasibility Trial.

@ast

Intensified Adjuvant IFADIC Ch ...... Randomized Feasibility Trial.

@en

prefLabel

Intensified Adjuvant IFADIC Ch ...... Randomized Feasibility Trial.

@ast

Intensified Adjuvant IFADIC Ch ...... Randomized Feasibility Trial.

@en

P1433

Q36674048-26ABF43C-1669-419D-9AD7-DBB7EC57109F

P1476

Q36674048-5B4471C8-F96D-40B2-8715-976C65CEA238

P2093

Q36674048-06832B00-8313-4A3C-BAF7-D23EB5794F3D

Q36674048-0C206229-F09C-4A46-9307-9286DDF3234F

Q36674048-1DC40F1B-BC53-42F9-A4E8-0AA7CD0F18C9

Q36674048-80064E54-BB1B-45D0-A0BF-E995C13CB29C

Q36674048-8DAE6BCA-2BEF-4B0E-8555-ACD389B70234

Q36674048-B592CC47-A121-4F30-A036-2D8F84A657C3

Q36674048-B6BB3619-2F8E-4F9A-9B17-F3D1FFE4A37C

Q36674048-BC4B0EA7-B70C-4B73-855B-8BF12E49C707

Q36674048-C5F49C2B-E073-40C5-B931-2CDBC3C6A27A

Q36674048-D562565F-8363-48DF-A3AB-DC0F62B4362D

P2860

Q36674048-180DA9DD-D0A3-4F4D-AB18-55B276594878

Q36674048-333ABB06-3A11-48CB-8D19-87BB7018FF4F

Q36674048-3442D8F5-0A41-4B79-87A4-CB5B02CEBE3E

Q36674048-3F8069C0-65BE-4B89-B17B-9C02C30E9319

Q36674048-5C679792-1A00-47C8-BB0E-FDABCA4A6F36

Q36674048-6A82AABC-A06D-4ED5-8C50-EFF236AD158D

Q36674048-7AED10FA-D5B0-4136-8547-BCF949F8DAFC

Q36674048-925E08C9-B0C7-45B8-8046-7F43D156A5E8

Q36674048-947D8322-3252-4799-90E3-771EEE82A0C9

Q36674048-9B90D4A3-2A8C-4E37-B235-B2890EBDCAFB

P304

Q36674048-567BF467-A5E1-4CD7-9341-B93CC6733419

P31

Q36674048-3F0F6890-4317-4118-94BA-0F0FDC761A22

P356

Q36674048-7CD96527-73F3-4EBE-AAB0-EC45B345C540

P433

Q36674048-171A72B1-AF45-4146-AC29-597EAA3243FC

P478

Q36674048-4489FADC-A1E4-40CA-9ABB-CDB30E426D10

P577

Q36674048-F17CCBDD-E931-4ECA-B69D-749197F3F65E

P698

Q36674048-6718B028-6DA1-489B-808C-D58B941797E4

P921

Q36674048-F6240580-AA09-4A33-AB0B-1D5EF23EE1D2

P932

Q36674048-66182C57-3C72-4195-8510-4A76CED56697

P356

P1433

P1476

Intensified Adjuvant IFADIC Ch ...... Randomized Feasibility Trial.

@en

P2093

C C Zielinski

http://www.w3.org/2001/XMLSchema#string

C Wiltschke

http://www.w3.org/2001/XMLSchema#string

E Schwameis

http://www.w3.org/2001/XMLSchema#string

G Amann

http://www.w3.org/2001/XMLSchema#string

J Widder

http://www.w3.org/2001/XMLSchema#string

M Dominkus

http://www.w3.org/2001/XMLSchema#string

P Ritschl

http://www.w3.org/2001/XMLSchema#string

R Kotz

http://www.w3.org/2001/XMLSchema#string

R Pötter

http://www.w3.org/2001/XMLSchema#string

R Windhager

http://www.w3.org/2001/XMLSchema#string

P2860

Dose response evaluation of adriamycin in human neoplasia

Efficacy of lenograstim on hematologic tolerance to MAID chemotherapy in patients with advanced soft tissue sarcoma and consequences on treatment dose-intensity.

Prognostic factors for the outcome of chemotherapy in advanced soft tissue sarcoma: an analysis of 2,185 patients treated with anthracycline-containing first-line regimens--a European Organization for Research and Treatment of Cancer Soft Tissue and

Randomized comparison of doxorubicin alone versus ifosfamide plus doxorubicin or mitomycin, doxorubicin, and cisplatin against advanced soft tissue sarcomas.

Adjuvant therapy for sarcomas.

The George Edelstyn memorial lecture: radiation in the management of malignant soft tissue tumours.

Chemotherapy of advanced soft-tissue sarcomas.

Cyclophosphamide, vincristine, adriamycin, and DTIC (CYVADIC) combination chemotherapy for the treatment of advanced sarcomas.

Adjuvant chemotherapy in the treatment of soft-tissue sarcoma.

Clinical impact of chemotherapy dose escalation in patients with hematologic malignancies and solid tumors.

P304

151-160

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1155/2000/126837

http://www.w3.org/2001/XMLSchema#string

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

4

http://www.w3.org/2001/XMLSchema#string

P577

2000-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

18521295

http://www.w3.org/2001/XMLSchema#string

P921

P932

2395444

http://www.w3.org/2001/XMLSchema#string